A benchmarking study comparing ovarian cancer diagnostics company Cleo Diagnostics (ASX: COV)’s blood test against ultrasound has been published in the scientific journal “Cancers” with positive outcomes. The study found that Cleo’s initial test for the surgical triage market significantly outperforms the current clinical workflows that use Cancer Antigen 125 (CA125) and ultrasound to predict
Read More
Clinical stage drug development company Syntara (ASX:SNT) is set to get a big boost in exposure within the blood cancer industry as it forges ahead with dosing patients in its Phase 2 clinical trial of SNT-5505 in combination with approved drug ruxolitinib. SNT-5505, a pan-LOX inhibitor designed to target myelofibrosis, a bone marrow cancer where
Read More
As diseases continue to adapt, the realm of medical diagnostics must intelligently progress to adeptly combat these changes. Timely interventions and treatments are crucial to improve patient outcomes and survival rates. There are approximately 14 medical diagnostics companies listed on the ASX, striving to pioneer the early detection of new diseases and make significant progress
Read More
Ranked fourth among countries with the highest HIV prevalence in the world, there were about 7.5 million people living with HIV in South Africa in 2021, and the number keeps growing. Subsequently, the HIV test market in South Africa is also growing as HIV testing initiatives have been implemented to increase access to testing and
Read More
Treating cancer is a primary goal of many biotech companies, but for any treatment to begin, physicians need a definitive diagnosis. We know that time is critical in disease diagnosis and initiating treatment sooner translates to better patient outcomes more often than not. The field of diagnostics is the yin to medical treatment’s yang. They
Read More
Your Friday crash course: Diagnostic biomarkers are in essence, used to determine whether or not a patient has a medical condition. Biomarkers can be molecular, histologic, radiographic and physiological, examples include heart rate, BMI and x-ray findings. Proteomics International Laboratories (ASX: PIQ) is taking molecular biomarkers to a whole new level, utilising proprietary biomarkers to
Read More